New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine
18 May 2012 | By Biogen Idec / Elan Corporation plc
Use of biomarker has potential to advance personalised treatment for MS patients...
List view / Grid view
News
NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN)
18 May 2012 | By Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals announce results of an investigational Phase 3 study...
Pfizer exploratory study measures effects of Lyrica (pregabalin) on brain activity in fibromyalgia patients
18 May 2012 | By Pfizer
Results of studies on Lyrica® announced...
GSK statement on tender offer to acquire Human Genome Sciences
18 May 2012 | By GlaxoSmithKline
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...
ArQule and Daiichi Sankyo announce completion of patient recruitment in Phase 3 clinical trial of Tivantinib in non-small cell lung cancer
18 May 2012 | By Daiichi Sankyo
ArQule and Daiichi Sankyo announced that recruitment of patients has been completed...
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients
17 May 2012 | By Novartis
Results from pivotal Phase III GLOW2 study...
Teva’s Board of Directors votes to re-elect Dr. Phillip Frost as Chairman of the Board
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
Amgen’s BiTE® Antibody Blinatumomab achieved high rate of complete response in adult patients with relapsed or refractory acute lymphoblastic leukemia
16 May 2012 | By Amgen
Updated results from a Phase 2 study...
GlaxoSmithKline completes transaction to increase its ownership in Theravance
16 May 2012 | By GlaxoSmithKline
GSK and Theravance, Inc. announced that following approval by Theravance...
Catalent announces winners of Global Academic Competition for Life Science Leaders of Tomorrow
16 May 2012 | By Catalent Pharma Solutions
“This competition allows us to acknowledge some of the world’s best emerging talent..."
Roche will report new data on important progress for people with advanced cancers at ASCO 2012
16 May 2012 | By Roche
Phase III data on Avastin in advanced colorectal and ovarian cancers...
Analysis of rilotumumab data identifies a potential predictive biomarker for patients with gastric or gastroesophageal cancer
16 May 2012 | By Amgen
Exploratory biomarker analysis results...
Avalanche and Lonza announce global manufacturing collaboration for AAV vectors for gene therapy
Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.
ASCO abstracts highlight late-stage Sanofi Oncology pipeline
16 May 2012 | By Sanofi
Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured...
Bristol-Myers Squibb Foundation announces $15 million expansion of Together on Diabetes® to China and India
15 May 2012 | By Bristol-Myers Squibb Company
Expansion of Together on Diabetes® initiative to China and India ...
